135 Publications (Page 5 of 6)
2010
Abstract 2216: Next-generation whole transcriptome sequencing of triple-negative breast tumors and normal tissues
Radovich, Milan⋅Radovich, Milan⋅Radovich, Milan⋅Clare, Susan E⋅Clare, Susan E⋅Clare, Susan E⋅Pardo, Ivanesa⋅Pardo, Ivanesa⋅Pardo, Ivanesa⋅Hancock, Bradley A⋅Hancock, Bradley A⋅Hancock, Bradley A⋅Kassem, Nawal⋅Kassem, Nawal⋅Kassem, Nawal⋅Sledge, George W⋅Sledge, George W⋅Sledge, George W⋅Rufenbarger, Connie⋅Rufenbarger, Connie⋅Rufenbarger, Connie⋅Storniolo, Anna Maria V⋅Storniolo, Anna Maria V⋅Storniolo, Anna Maria V⋅Mathieson, Theresa⋅Mathieson, Theresa⋅Mathieson, Theresa⋅Sun, Jie⋅Sun, Jie⋅Sun, Jie⋅Henry, Jill E⋅Henry, Jill E⋅Henry, Jill E⋅Lillemoe, Heather A⋅Lillemoe, Heather A⋅Lillemoe, Heather A⋅Hilligoss, Eric E⋅Hilligoss, Eric E⋅Hilligoss, Eric E⋅Elliott, James S⋅Elliott, James S⋅Elliott, James S⋅Richt, Ryan⋅Richt, Ryan⋅Richt, Ryan⋅Hickenbotham, Matthew⋅Hickenbotham, Matthew⋅Hickenbotham, Matthew⋅Glasscock, Jarret⋅Glasscock, Jarret⋅Glasscock, Jarret⋅Liu, Yunlong⋅Liu, Yunlong⋅Liu, Yunlong⋅Schneider, Bryan P⋅Schneider, Bryan P and Schneider, Bryan P
Cancer Research, vol. 70, (no. 8 Supplement), pp. 2216, 2010-04-15. | Journal Article
 
A phase I dose escalation and pharmacokinetic study of vatalanib (PTK787/ZK 222584) in combination with paclitaxel in patients with advanced solid tumors.
Chiorean, E G⋅Chiorean, Elena G⋅Malireddy, Srikar⋅Malireddy, Srikar⋅Younger, Anne E⋅Younger, Anne E⋅Jones, David R⋅Jones, David R⋅Waddell, Mary-Jane⋅Waddell, Mary-jane⋅Sloop, Melissa I⋅Sloop, Melissa I⋅Yu, Menggang⋅Yu, Menggang⋅Hall, Stephen D⋅Hall, Stephen D⋅Schneider, Bryan⋅Schneider, Bryan P⋅Sweeney, Christopher J and Sweeney, Christopher J
Cancer chemotherapy and pharmacology, vol. 66, (no. 3), pp. 441-8, 2010/Aug. | Journal Article
 
Compliance differences between patients with breast cancer in university and county hospitals.
Komenaka, Ian K⋅Pennington, Robert E⋅Schneider, Bryan P⋅Hsu, Chiu-Hsieh⋅Norton, Laura E⋅Clare, Susan E⋅Zork, Noelia M and Goulet, Robert J
Clinical breast cancer, vol. 10, (no. 5), pp. 385-91, 2010/Oct/1. | Journal Article
 
Paclitaxel plus bevacizumab in patients with chemosensitive relapsed small cell lung cancer: a safety, feasibility, and efficacy study from the Hoosier Oncology Group.
Jalal, Shadia⋅Jalal, Shadia I⋅Bedano, Pablo⋅Bedano, Pablo⋅Einhorn, Lawrence⋅Einhorn, Lawrence H⋅Bhatia, Sumeet⋅Bhatia, Sumeet⋅Ansari, Rafat⋅Ansari, Rafat⋅Bechar, Naftali⋅Bechar, Naftali⋅Koneru, Karuna⋅Koneru, Karuna⋅Govindan, Ramaswamy⋅Govindan, Ramaswamy⋅Wu, Jingwei⋅Wu, Jingwei⋅Yu, Menggang⋅Yu, Menggang⋅Schneider, Bryan P⋅Schneider, Bryan⋅Hanna, Nasser and Hanna, Nasser
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, vol. 5, (no. 12), pp. 2008-11, 2010/Dec. | Journal Article
 
Resequencing of the vascular endothelial growth factor promoter reveals haplotype structure and functional diversity.
Radovich, Milan⋅Hancock, Bradley A⋅Kassem, Nawal⋅Mi, Deming⋅Skaar, Todd C and Schneider, Bryan P
Angiogenesis, vol. 13, (no. 3), pp. 211-8, 2010/Sep. | Journal Article
2009
Anti-VEGF therapy as adjuvant therapy: clouds on the horizon?
Schneider, Bryan P and Sledge, George W
Breast cancer research : BCR, vol. 11, (no. 3), pp. 303, 2009. | Journal Article
 
A pilot study of vascular endothelial growth factor inhibition with bevacizumab in patients with lymphedema following breast cancer treatment.
Miller, K⋅Christmon, D⋅Perkins, S⋅Sun, J⋅Schneider, B⋅Storniolo, A⋅Clare, S⋅Ozerdem, U and Sledge, G
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 27, (no. 15_suppl), pp. 9523, May 20, 2009. | Journal Article
 
Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy.
Otte, Julie L⋅Flockhart, David A⋅Hayes, Daniel F⋅Storniolo, Anna M⋅Stearns, Vered⋅Schneider, Bryan P⋅Henry, Norah L⋅Azzouz, Faouzi⋅Nguyen, Anne⋅Lemler, Suzanne⋅Hayden, Jill⋅Jeter, Stacie⋅Wright, Laurie and Carpenter, Janet S
Menopause (New York, N.Y.), vol. 16, (no. 4), pp. 653-9, 2009 Jul-Aug. | Journal Article
 
Evaluating the role of serotonin in hot flashes after breast cancer using acute tryptophan depletion.
Carpenter, Janet S⋅Carpenter, Janet⋅Carpenter, Janet⋅Yu, Menggang⋅Yu, Menggang⋅Yu, Menggang⋅Wu, Jingwei⋅Wu, Jingwei⋅Wu, Jingwei⋅Von Ah, Diane⋅Von Ah, Diane⋅Von Ah, Diane⋅Milata, Jennifer⋅Milata, Jennifer⋅Milata, Jennifer⋅Otte, Julie⋅Otte, Julie L⋅Otte, Julie⋅Johns, Shelley⋅Johns, Shelley⋅Johns, Shelley⋅Schneider, Bryan P⋅Schneider, Bryan⋅Schneider, Bryan⋅Storniolo, Anna⋅Storniolo, Anna⋅Storniolo, Anna M⋅Salomon, Ronald⋅Salomon, Ronald⋅Salomon, Ronald⋅Desta, Zeuresenay⋅Desta, Zeuresenay⋅Desta, Zeuresenay⋅Cao, Donghua⋅Cao, Donghua⋅Cao, Donghua⋅Jin, Yan⋅Jin, Yan⋅Jin, Yan⋅Philips, Santosh⋅Philips, Santosh⋅Philips, Santosh⋅Skaar, Todd C⋅Skaar, Todd and Skaar, Todd
Menopause (New York, N.Y.), vol. 16, (no. 4), pp. 644-52, 2009 Jul-Aug. | Journal Article
 
Exploratory study evaluating the association of polymorphisms of angiogenesis genes with hot flashes
Schneider, Bryan P⋅Radovich, Milan⋅Flockhart, David A⋅Carpenter, Janet S⋅Li, Lang⋅Robarge, Jason D⋅Storniolo, Anna M⋅Hancock, Bradley A⋅Skaar, Todd and Sledge, George W
Breast Cancer Research and Treatment, vol. 116, (no. 3), pp. 543-9, Aug 2009. | Journal Article
 
In Reply
Schneider, Bryan P⋅Schneider, Bryan P⋅Schneider, Bryan P⋅Wang, Molin⋅Wang, Molin⋅Wang, Molin⋅Sledge, George W⋅Sledge, George W⋅Sledge, George W⋅Gray, Robert J⋅Gray, Robert J⋅Gray, Robert J⋅Flockhart, David A⋅Flockhart, David A⋅Flockhart, David A⋅Miller, Kathy D⋅Miller, Kathy D and Miller, Kathy D
Journal of Clinical Oncology, vol. 27, (no. 8), pp. 1343, 2009-03-10. | Journal Article
 
Intrinsic subtype-associated changes in the plasma proteome in breast cancer
Nakshatri, Harikrishna⋅Qi, G.⋅You, J.⋅Kerry, B.⋅Schneider, B.⋅Zon, R.⋅Buck, C.⋅Regnier, Fred E and Wang, Mu
Proteomics Clinical Applications, vol. 3, (no. 11), pp. 1305-1313, 2009. | Journal Article
 
The role of vascular endothelial growth factor genetic variability in cancer.
Schneider, Bryan P⋅Radovich, Milan and Miller, Kathy D
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 15, (no. 17), pp. 5297-302, 2009/Sep/1. | Journal Article
2008
A 25-year single institution experience with surgery for primary mediastinal nonseminomatous germ cell tumors.
Kesler, Kenneth A⋅Rieger, Karen M⋅Hammoud, Zane T⋅Kruter, Laura E⋅Perkins, Susan M⋅Turrentine, Mark W⋅Schneider, Bryan P⋅Einhorn, Lawrence H and Brown, John W
The Annals of thoracic surgery, vol. 85, (no. 2), pp. 371-8, 2008/Feb. | Journal Article
 
A phase I dose escalation trial of the VEGFR tyrosine kinase inhibitor, PTK787/ ZK222584 (PTK/ZK), used in combination with paclitaxel in patients with advanced solid tumors with pharmacokinetic (PK) analysis.
Malireddy, S R⋅Chiorean, E G⋅Younger, A⋅Jones, D⋅Waddell, M⋅Margol, M⋅Hall, S⋅Schneider, B P and Sweeney, C J
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 26, (no. 15_suppl), pp. 14521, May 20, 2008. | Journal Article
 
A phase II study of oral MKC-1 for metastatic breast cancer (MBC).
Schneider, B P⋅Karwal, M⋅Laufman, L⋅Sylvester, L⋅Taylor, M A⋅Sidor, C⋅Hannah, A⋅Arnott, J and Miller, K D
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 26, (no. 15_suppl), pp. 1046, May 20, 2008. | Journal Article
 
Association of polymorphisms of angiogenesis genes with breast cancer
Schneider, Bryan P⋅Radovich, Milan⋅Sledge, George W⋅Robarge, Jason D⋅Li, Lang⋅Storniolo, Anna M⋅Lemler, Suzanne⋅Nguyen, Anne T⋅Hancock, Bradley A⋅Stout, Michael⋅Skaar, Todd and Flockhart, David A
Breast Cancer Research and Treatment, vol. 111, (no. 1), pp. 157-63, Sep 2008. | Journal Article
 
Association of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 genetic polymorphisms with outcome in a trial of paclitaxel compared with paclitaxel plus bevacizumab in advanced breast cancer: ECOG 2100.
Schneider, Bryan P⋅Schneider, Bryan⋅Wang, Molin⋅Wang, Molin⋅Radovich, Milan⋅Radovich, Milan⋅Sledge, George W⋅Sledge, George⋅Badve, Sunil⋅Badve, Sunil⋅Thor, Ann⋅Thor, Ann⋅Flockhart, David⋅Flockhart, David A⋅Hancock, Bradley⋅Hancock, Bradley⋅Davidson, Nancy E⋅Davidson, Nancy⋅Gralow, Julie R⋅Gralow, Julie⋅Dickler, Maura⋅Dickler, Maura⋅Perez, Edith A⋅Perez, Edith⋅Cobleigh, Melody⋅Cobleigh, Melody⋅Shenkier, Tamara⋅Shenkier, Tamara⋅Edgerton, Susan⋅Edgerton, Susan⋅Miller, Kathy D and Miller, Kathy
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 26, (no. 28), pp. 4672-8, 2008/Oct/1. | Journal Article
 
Triple-negative breast cancer: risk factors to potential targets.
Schneider, Bryan P⋅Winer, Eric P⋅Foulkes, William⋅Garber, Judy⋅Perou, Charles M⋅Richardson, Andrea⋅Sledge, George W and Carey, Lisa A
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 14, (no. 24), pp. 8010-8, 2008/Dec/15. | Journal Article
2007
A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-[alpha]2b in patients with solid tumors
Schneider, Bryan⋅Schneider, Bryan⋅Fukunaga, Anna⋅Fukunaga, Anna⋅Murry, Daryl⋅Murry, Daryl⋅Yoder, Christy⋅Yoder, Christy⋅Fife, Karen⋅Fife, Karen⋅Foster, Anne⋅Foster, Anne⋅Rosenberg, Leslie⋅Rosenberg, Leslie⋅Kelich, Stephanie⋅Kelich, Stephanie⋅Li, Lang⋅Lang, Li⋅Sweeney, Christopher and Sweeney, Christopher
Cancer Chemotherapy and Pharmacology, vol. 59, (no. 2), pp. 261-8, Feb 2007. | Journal Article
 
A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-alpha2b in patients with solid tumors.
Schneider, Bryan⋅Schneider, Bryan P⋅Fukunaga, Anna⋅Fukunaga, Anna⋅Murry, Daryl⋅Murry, Daryl J⋅Yoder, Christy⋅Yoder, Christy⋅Fife, Karen⋅Fife, Karen⋅Foster, Anne⋅Foster, Anne⋅Rosenberg, Leslie⋅Rosenberg, Leslie⋅Kelich, Stephanie⋅Kelich, Stephanie⋅Li, Lang⋅Li, Lang⋅Sweeney, Christopher and Sweeney, Christopher J
Cancer chemotherapy and pharmacology, vol. 59, (no. 2), pp. 261-8, 2007/Feb. | Journal Article
 
Drug insight: VEGF as a therapeutic target for breast cancer.
Schneider, Bryan P and Sledge, George W
Nature clinical practice. Oncology, vol. 4, (no. 3), pp. 181-9, 2007/Mar. | Journal Article
 
Is the Blood-Brain Barrier Relevant in Metastatic Germ Cell Tumor?
Azar, Jose⋅Azar, Jose M⋅Schneider, Bryan P⋅Schneider, Bryan⋅Einhorn, Lawrence H and Einhorn, Lawrence
International Journal of Radiation Oncology, Biology, & Physics, vol. 69, (no. 1), pp. 163-166, 2007. | Journal Article
2006
Analysis of angiogenesis genes from paraffin-embedded breast tumor and lymph nodes
Schneider, Bryan P⋅Skaar, Todd⋅Sledge, George W⋅Badve, Sunil S⋅Li, Lang and Flockhart, David A
Breast Cancer Research and Treatment, vol. 96, (no. 3), pp. 209-15, Apr 2006. | Journal Article
 
Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants
Stearns, Vered⋅Schneider, Bryan P⋅Henry, Norah Lynn⋅Hayes, Daniel F and Flockhart, David A
Nature Reviews. Cancer, vol. 6, (no. 11), pp. 886-93, Nov 2006. | Journal Article